Clinical Trial Update: Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing vedolizumab versus dose-intensive adalimumab in Crohn's disease patients who have lost response or show biomarker activity to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Entyvio (vedolizumab)
• Humira (adalimumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Crohn's Disease | Phase 4 | Status: RECRUITING